Acrux Limited (ACR) - Announcements

$0.180

Latest company announcements for Acrux Limited (ACR)

Sector Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
Health Care $30 Acrux's third generic dossier accepted by FDA for review 19 Aug 2019 9:09AM $0.175 $0.180 $0.180 risen by 2.86%
Health Care $30 Appendix 3B 15 Aug 2019 12:30PM $0.180 $0.180 $0.180 fallen by 0%
Health Care $30 Investor Presentation - Bioshares Summit 29 Jul 2019 10:32AM $0.180 $0.180 $0.180 fallen by 0%
Health Care $30 Appendix 3B 17 Jun 2019 6:10PM $0.190 $0.180 $0.180 fallen by 5.26%
Health Care $30 Change in Company Secretary 7 Jun 2019 8:24AM $0.195 $0.180 $0.180 fallen by 7.69%
Health Care $30 Jublia Patent Litigation Settlement 3 Apr 2019 12:09PM $0.185 $0.180 $0.180 fallen by 2.70%
Health Care $30 Becoming a substantial holder 28 Feb 2019 2:37PM $0.165 $0.180 $0.180 risen by 9.09%
Health Care $30 Investor Presentation 25 Feb 2019 10:44AM $0.165 $0.180 $0.180 risen by 9.09%
Health Care $30 Appendix 4D and Half-Year Financial Report to 31 Dec 2018 21 Feb 2019 3:47PM $0.180 $0.180 $0.180 fallen by 0%
Health Care $30 Appendix 3B 18 Feb 2019 12:43PM $0.175 $0.180 $0.180 risen by 2.86%
Health Care $30 Appendix 3B 5 Feb 2019 4:21PM $0.180 $0.180 $0.180 fallen by 0%
Health Care $30 Acrux Receives $2.057m R&D Tax Incentive Rebate 21 Jan 2019 3:42PM $0.200 $0.180 $0.180 fallen by 10%
Health Care $30 End of Year Update 20 Dec 2018 8:51AM $0.180 $0.180 $0.180 fallen by 0%
Health Care $30 Appendix 3B 23 Nov 2018 4:52PM $0.195 $0.180 $0.180 fallen by 7.69%
Health Care $30 Change of Director's Interest Notice 13 Nov 2018 5:40PM $0.215 $0.180 $0.180 fallen by 16.28%
Health Care $30 2018 AGM Results 1 Nov 2018 12:42PM $0.220 $0.180 $0.180 fallen by 18.18%
Health Care $30 2018 AGM Script 1 Nov 2018 8:44AM $0.215 $0.180 $0.180 fallen by 16.28%
Health Care $30 2018 AGM Presentation 1 Nov 2018 8:40AM $0.215 $0.180 $0.180 fallen by 16.28%
Health Care $30 Change of Director's Interest Notice 19 Oct 2018 8:58AM $0.235 $0.180 $0.180 fallen by 23.40%
Health Care $30 Acrux has second generic dossier accepted for review by FDA 17 Oct 2018 8:58AM $0.210 $0.180 $0.180 fallen by 14.29%
Health Care $30 Acrux confirms patent challenge for generic of efinaconazole 24 Sep 2018 9:11AM $0.275 $0.180 $0.180 fallen by 34.55%
Health Care $30 Notice of 2018 Annual General Meeting/Proxy Form 21 Sep 2018 8:34AM $0.270 $0.180 $0.180 fallen by 33.33%
Health Care $30 2018 Annual Report 21 Sep 2018 8:33AM $0.270 $0.180 $0.180 fallen by 33.33%
Health Care $30 Updated Acrux Investor Presentation 18 Sep 2018 8:40AM $0.230 $0.180 $0.180 fallen by 21.74%
Health Care $30 2018 Annual Results and Investor Presentation 16 Aug 2018 4:55PM $0.215 $0.180 $0.180 fallen by 16.28%

1 - 25 of 305 results

Page 1 of 13

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.